[1]张宇思 综述 欧阳忠* 审校.乳腺癌前哨淋巴结引流模式研究及应用进展[J].中国微创外科杂志,2022,01(6):505-509.
点击复制

乳腺癌前哨淋巴结引流模式研究及应用进展()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2022年6期
页码:
505-509
栏目:
文献综述
出版日期:
2022-10-11

文章信息/Info

作者:
张宇思 综述 欧阳忠* 审校
(厦门大学附属第一医院乳腺外科,厦门361003)
文献标志码:
B

参考文献/References:

[1]Tanis PJ,Nieweg OE,Valdés Olmos RA,et al.Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.J Am Coll Surg,2001,192(3):399-409.
[2]Suami H,Pan WR,Mann GB,et al.The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy:a human cadaver study.Ann Surg Oncol,2008,15(3):863-871.
[3]Kern KA.Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.J Am Coll Surg,1999,189(6):539-545.
[4]Li X,Chen S,Jiang L,et al.Precise intraoperative sentinel lymph node biopsies guided by lymphatic drainage in breast cancer.Oncotarget,2017,8(38):63064-63072.
[5]Wang M,Zhou W,Zhao Y,et al.A novel finding of sentinel lymphatic channels in early stage breast cancer patients: which may influence detection rate and falsenegative rate of sentinel lymph node biopsy.PLoS One,2012,7(12):e51226.
[6]Wang Y,Zhou W,Li C,et al.Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrastenhanced ultrasound (CEUS) in breast cancer patients.World J Surg Oncol,2017,15(1):127.
[7]Li H,Jun Z,ZhiCheng G,et al.Factors that affect the false negative rate of sentinel lymph node mapping with methylene blue dye alone in breast cancer.J Int Med Res,2019,47(10):4841-4853.
[8]Shimazu K,Miyake T,Tanei T,et al.Realtime visualization of lymphatic flow to sentinel lymph nodes by contrastenhanced ultrasonography with sonazoid in patients with breast cancer.Ultrasound Med Biol,2019,45(10):2634-2640.
[9]Zhu Y,Fan X,Yang D,et al.Contrastenhanced ultrasound for precise sentinel lymph node biopsy in women with early breast cancer:a preliminary study.Diagnostics (Basel),2021,11(11):2104.
[10]Zhong J,Sun DS,Wei W,et al.Contrastenhanced ultrasoundguided fineneedle aspiration for sentinel lymph node biopsy in earlystage breast cancer.Ultrasound Med Biol,2018,44(7):1371-1378.
[11]黄雷,余晋刚,叶建平,等.CT淋巴造影联合三维可视技术在乳腺癌淋巴回流路径研究中的应用.实用医学杂志,2021,37(14):1861-1865.
[12]白海亚,刘慧民,杨萍,等.乳腺癌前哨淋巴结活检中吲哚菁绿示踪剂的价值分析.中国微创外科杂志,2020,20(1):14-18.
[13]邢月,隋阳,吴长君.经皮超声造影在乳腺癌前哨淋巴结诊断中的研究进展.中华医学超声杂志(电子版),2021,18(2):227-230.
[14]章焱华.吲哚菁绿荧光技术应用于乳腺癌前哨淋巴结活检的可行性研究进展.实用癌症杂志,2019,34(10):1738-1740.
[15]王玮,李建彬.乳腺癌内乳淋巴结转移率及相关因素研究进展.中华肿瘤杂志,2019,41(11):801-804.
[16]周梦,金梅,王琳,等.乳腺癌内乳区前哨淋巴结临床研究.中国现代医学杂志,2018,28(3):92-96.
[17]Bi Z,Chen P,Song XR,et al.The hypothesis of internal mammary lymph node drainage chain in breast cancer.Future Oncol,2020,16(21):1489-1491.
[18]van der Ent FW,Kengen RA,van der Pol HA,et al.Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer.Ann Surg,2001,234(1):79-84.
[19]邱鹏飞,王永胜.乳腺癌内乳淋巴结精准分期与个体化治疗.中国肿瘤外科杂志,2020,12(4):306-310,315.
[20]Cao XS,Yang GR,Cong BB,et al.The lymphatic drainage pattern of internal mammary sentinel lymph node identified by small particle radiotracer (99mTcdextran 40) in breast.Cancer Res Treat,2019,51(2):483-492.
[21]丛斌斌,邱鹏飞,杨国仁,等.乳腺癌内乳前哨淋巴结活检新型示踪技术验证研究.中华内分泌外科杂志,2015,9(2):109-113.
[22]中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2021年版).中国癌症杂志,2021,31(10):954-1040.
[23]Lyman GH,Somerfield MR,Bosserman LD,et al.Sentinel lymph node biopsy for patients with earlystage breast cancer:American Society of Clinical Oncology clinical practice guideline update.J Clin Oncol,2017,35(5):561-564.
[24]Kothari MS,Rusby JE,Agusti AA,et al.Sentinel lymph node biopsy after previous axillary surgery:a review.Eur J Surg Oncol,2012,38(1):8-15.
[25]Yoon CI,Ahn SG,Kim D,et al.Repeat sentinel lymph node biopsy for ipsilateral breast tumor recurrence after breast conserving surgery with sentinel lymph node biopsy: pooled analysis using data from a systematic review and two institutions.Front Oncol,2020,10:518568.
[26]Sávolt á,Cserni G,Lázár G,et al.Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.Eur J Surg Oncol,2019,45(10):1835-1838.
[27]Tada K,Nishimura S,Miyagi Y,et al.The effect of an old surgical scar on sentinel node mapping in patients with breast cancer:a report of five cases.Eur J Surg Oncol,2005,31(8):840-844.
[28]HerreraMartínez Y,Fernández López R,BonillaDamiá á,et al.Aberrant lymphatic drainage in relapsed breast carcinoma:the usefulness of the lymphoscintigraphy.Breast J,2020,26(4):771-772.
[29]Vugts G,MaaskantBraat AJ,Voogd AC,et al.Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.Breast Cancer Res Treat,2015,153(3):549-556.
[30]Ryu JM,Chae BJ,Lee JE,et al.Aberrant lymphatic drainage in the contralateral axilla in patients with isolated ipsilateral breast tumor recurrence.J Clin Med,2020,9(4):1192.
[31]Ahmed M,Baker R,Rubio IT.Metaanalysis of aberrant lymphatic drainage in recurrent breast cancer.Br J Surg,2016,103(12):1579-1588.
[32]Sato A,Sakai T,Iwase T,et al.Altered lymphatic drainage patterns in reoperative sentinel lymph node biopsy for ipsilateral breast tumor recurrence.Radiat Oncol,2019,14(1):159.
[33]Kuemmel S,Holtschmidt J,Gerber B,et al.Prospective,multicenter,randomized phase III trial evaluating the impact of lymphoscintigraphy as part of sentinel node biopsy in early breast cancer:SenSzi (GBG80) trial.J Clin Oncol,2019,37(17):1490-1498.
[34]Hindié E.Skipping the lymphoscintigraphy step during sentinel node procedures in breast cancer:what information are we missing?J Clin Oncol,2019,37(29):2704-2705.
[35]Poodt I,Vugts G,MaaskantBraat A,et al.Risk of regional recurrence after negative repeat sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence.Ann Surg Oncol,2018,25(5):1312-1321.
[36]Mansel RE,MacNeill F,Horgan K,et al.Results of a national training programme in sentinel lymph node biopsy for breast cancer.Br J Surg,2013,100(5):654-661.

备注/Memo

备注/Memo:
*通讯作者,Email:oyzlyl@163.com
更新日期/Last Update: 2022-10-11